Fubon Financial Announces Fubon Life's Investment in Private Fund Transpose Platform BOV III Cayman, L.P.

1. Name and nature of the target (if preferred shares, specify issuance terms such as dividend rate): Transpose Platform BOV III Cayman, L.P. private fund

2. Date of occurrence: 115/06/16

3. Number of units, price per unit, and total transaction amount: No transaction units, no unit price, total subscription amount not exceeding $28 million USD

4. Counterparty and its relationship with the company (if the counterparty is an individual and not a related party, name disclosure may be omitted): Transpose Platform Management, LLC, none

5. If the counterparty is a related party, state the reason for selecting them, previous transferor, relationship among previous transferor, company, and counterparty, transfer date, and amount: Not applicable

6. If the target's owner was a related party of the company within the past five years, disclose the related party's acquisition and disposal date, price, and relationship with the company at the time: Not applicable

7. Matters regarding the disposal of receivables (including types of collateral attached to disposed receivables; if receivables from related parties, disclose the party's name and book value of receivables): Not applicable

8. Gain (or loss) from disposal (not applicable for acquisition of securities) (if deferred, list recognition details): Not applicable

9. Delivery or payment terms (including payment period and amount), contractual restrictions, and other important agreements: Delivery or payment terms: as stipulated in the private fund agreement Contractual restrictions and other important agreements: as stipulated in the private fund agreement

10. Decision-making method for this transaction, basis for price determination, and decision-making unit: Decision-making method and price basis: as stipulated in the private fund agreement Decision-making unit: according to the company's approval authority

11. Net asset value per share of the securities-issuing company: Not applicable

12. Difference between private placement reference price and per-unit transaction price exceeding 20%: Not applicable

13. Cumulative number, amount, ownership percentage, and rights restrictions (e.g., pledge status) of securities held to date (including this transaction): Holding company: none Life: no transaction units, not exceeding $28 million USD, approximately 8.75%, none

14. Proportion of private securities investment (including this transaction) to total assets and equity attributable to parent company owners in the latest financial statements, and operating capital amount: Holding company: 29.84%, 36.1%, not applicable

15. Manager and brokerage fees: Not applicable

16. Specific purpose or use of acquisition or disposal: For life insurance capital deployment under insurance regulations

17. Dissenting directors' opinions on this transaction: Not applicable

18. Whether this transaction is a related-party transaction: No

19. Board approval date: Not applicable

20. Supervisor acknowledgment or audit committee approval date: Not applicable

21. Whether auditors issued an adverse opinion on this transaction: No

22. Name of accounting firm: Hongwei Certified Public Accountants

23. Auditor name: Lai Chia-Yi

24. Auditor license number: Taiwan Finance Certificate Registration (6) No. 4408

25. Other disclosures: None